Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant.
Pediatr Int
; 58(5): 411-414, 2016 May.
Article
en En
| MEDLINE
| ID: mdl-26710929
ABSTRACT
We report a case of early onset sepsis caused by (CTX for cefotaximase and M for Munich)-type extended-spectrum ß-lactamase-producing Escherichia coli (ESBL E. coli) in a preterm infant weighing 601 g. He was given meropenem and treated for endotoxin absorption with polymyxin B-immobilized fibers with only 8 mL of priming volume. The patient survived without any short-term neurological or respiratory sequelae. The choice of antibiotics is particularly important in seriously ill neonates with sepsis due to ESBL-producing organisms. Polymyxin B hemoperfusion might be an innovative therapy for severe neonatal sepsis and could improve outcome even in an extremely low-birthweight infant.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Pediatr Int
Asunto de la revista:
PEDIATRIA
Año:
2016
Tipo del documento:
Article
País de afiliación:
Japón